ESMO Targeted Anticancer Therapies Congress 2024

Paris
#AI #Antibody drug conjugate (ADC) #DNA #ESMO #ESMO Targeted Anticancer Therapies Congress 2024 #RNA #Storm Therapeutics

Conversations from ESMO Targeted Anticancer Therapies Congress 2024 

DDW’s Megan Thomas caught up with Oliver Rausch, Chief Scientific Officer at Storm Therapeutics, following the ESMO Targeted Anticancer Therapies Congress 2024, a global meeting focusing on promising new anticancer targets and agents, focusing on those in early phase clinical development. Rausch gave an update on the latest developments from… Read More

#Exclusive Content